Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arthritis × Magnetic Resonance Spectroscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 50 Carcinoma, Non-Small-Cell Lung 31 Lung Neoplasms 26 Breast Neoplasms 25 Glioblastoma 22 Glioma 18 Multiple Myeloma 16 Pancreatic Neoplasms 15 Lymphoma 15 Carcinoma, Renal Cell 15 Urinary Bladder Neoplasms 13 Sarcoma 13 Lymphoma, Large B-Cell, Diffuse 13 Brain Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 10 Oropharyngeal Neoplasms 9 Neuroblastoma 9 Melanoma 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Follicular 9 Ependymoma 9 Central Nervous System Neoplasms 9 Astrocytoma 9 Ovarian Neoplasms 8 Mouth Neoplasms 8 Medulloblastoma 8 Wilms Tumor 7 Triple Negative Breast Neoplasms 7 Rhabdoid Tumor 7

Interventions

upadacitinib 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07284563 2025-12-16

Ultralow Dose PET Imaging for 18F-NaF Uptake

Nuclear Imaging Institute

Phase 2 Recruiting

Arthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡